Kopran Balance Sheet Annual

Trade

BSE: 524280 | NSE: KOPRAN | ISIN: INE082A01010 | Sector: Biotechnology & Drugs

220.55 +0.95 (0.43%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	14.20	0.12	0.12	0.87
Short Term Investments	0.95	4.88	51.08	5.09
Cashand Short Term Investments	15.15	12.27	56.95	6.78
Accounts Receivable- Trade Net	212.33	162.63	128.35	123.40
Total Receivables Net	213.78	165.15	129.21	124.25
Total Inventory	138.49	130.61	149.94	100.00
Other Current Assets Total	86.62	87.49	76.43	44.56
Total Current Assets	454.03	399.07	414.87	276.95
Property/ Plant/ Equipment Total- Net	256.69	218.48	175.55	146.36
Goodwill Net	0.01	0.01	0.01	0.01
Intangibles Net	21.60	16.08	10.68	8.72
Long Term Investments	0.06	0.06	0.06	0.05
Note Receivable- Long Term	4.76	14.33	8.19	6.09
Other Long Term Assets Total	6.10	1.67	1.53	1.22
Total Assets	743.25	649.70	610.89	439.38
Accounts Payable	113.09	87.38	62.30	85.91
Notes Payable/ Short Term Debt	82.63	57.35	53.71	43.08
Other Currentliabilities Total	22.82	30.27	33.49	29.59
Total Current Liabilities	218.53	176.97	151.59	160.68
Long Term Debt	16.60	17.24	18.62	21.16
Total Long Term Debt	16.60	17.89	18.77	21.21
Total Debt	99.23	77.07	74.55	66.30
Deferred Income Tax	7.87	7.08	6.27	4.99
Other Liabilities Total	9.00	8.51	8.09	7.47
Total Liabilities	252.00	210.45	184.72	194.35
Common Stock Total	48.21	48.21	48.21	43.25
Retained Earnings( Accumulated Deficit)	443.03	144.74	131.97	77.43
Total Equity	491.25	439.25	426.17	245.03
Total Liabilities Shareholders' Equity	743.25	649.70	610.89	439.38
Total Common Shares Outstanding	4.82	4.82	4.82	4.33
Tangible Book Valueper Share Common Eq	97.41	87.77	86.18	54.64
Cash	-	7.28	5.75	0.82
Prepaid Expenses	-	3.54	2.35	1.35
Property/ Plant/ Equipment Total- Gross	-	285.10	230.20	190.73
Accumulated Depreciation Total	-	-66.62	-54.65	-44.37
Accrued Expenses	-	0.14	0.02	0.09
Current Portof LT Debt/ Capital Leases	-	1.83	2.06	2.01
Capital Lease Obligations	-	0.65	0.15	0.06
Additional Paid- In Capital	-	243.79	243.79	122.27
Other Equity Total	-	2.51	2.20	2.08